Your browser doesn't support javascript.
loading
The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice.
Jiang, Xiaoliang; Li, Huadong; Liu, Yong; Bao, Linlin; Zhan, Lingjun; Gao, Hong; Deng, Wei; Xue, Jing; Liu, Jiangning; Liu, Xing; Li, Junli; Wang, Jie; Wu, Shuang; Yan, Mingzhe; Luo, Wei; Jose, Pedro A; Qin, Chuan; Yang, Xiuhong; Zhang, Dingyu; Yang, Zhiwei.
Afiliação
  • Jiang X; Key Laboratory of Human Disease Comparative Medicine Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical Co
  • Li H; Jinyintan Hospital, Wuhan, China, Dongxihu District, Wuhan, 430023, People's Republic of China.
  • Liu Y; Department of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, People's Republic of China.
  • Bao L; Key Laboratory of Human Disease Comparative Medicine Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical Co
  • Zhan L; Key Laboratory of Human Disease Comparative Medicine Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical Co
  • Gao H; Key Laboratory of Human Disease Comparative Medicine Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical Co
  • Deng W; Key Laboratory of Human Disease Comparative Medicine Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical Co
  • Xue J; Key Laboratory of Human Disease Comparative Medicine Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical Co
  • Liu J; Key Laboratory of Human Disease Comparative Medicine Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical Co
  • Liu X; Key Laboratory of Human Disease Comparative Medicine Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical Co
  • Li J; Key Laboratory of Human Disease Comparative Medicine Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical Co
  • Wang J; Key Laboratory of Human Disease Comparative Medicine Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical Co
  • Wu S; Jinyintan Hospital, Wuhan, China, Dongxihu District, Wuhan, 430023, People's Republic of China.
  • Yan M; Jinyintan Hospital, Wuhan, China, Dongxihu District, Wuhan, 430023, People's Republic of China.
  • Luo W; Department of Clinical Laboratory, General Hospital of Tianjin Medical University, No.154, Anshan Road, Heping District, Tianjin, 300052, People's Republic of China.
  • Jose PA; Division of Renal Diseases and Hypertension, Department of Medicine, and Department of Pharmacology/Physiology, The George Washington University School of Medicine and Health Sciences, Washington, DC, 20052, USA.
  • Qin C; Key Laboratory of Human Disease Comparative Medicine Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical Co
  • Yang X; Department of Physiology, School of Basic Medical Sciences, North China University of Science and Technology, 57 Jianshe South Rd, Tangshan City, Hebei, 063000, People's Republic of China.
  • Zhang D; Jinyintan Hospital, Wuhan, China, Dongxihu District, Wuhan, 430023, People's Republic of China.
  • Yang Z; Key Laboratory of Human Disease Comparative Medicine Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical Co
J Cardiovasc Transl Res ; 15(1): 38-48, 2022 02.
Article em En | MEDLINE | ID: mdl-34973134
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Hipertensão Limite: Animals / Humans Idioma: En Revista: J Cardiovasc Transl Res Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Hipertensão Limite: Animals / Humans Idioma: En Revista: J Cardiovasc Transl Res Ano de publicação: 2022 Tipo de documento: Article